We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Boosting Drug Development Success With More Precise Animal Models
News

Boosting Drug Development Success With More Precise Animal Models

Boosting Drug Development Success With More Precise Animal Models
News

Boosting Drug Development Success With More Precise Animal Models

Credit: Nature_Blossom/ Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Boosting Drug Development Success With More Precise Animal Models"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Verifying the efficacy and safety of a drug, clinical trials are a hurdle that must be cleared before a new drug hits the market. Conducting them on humans would be the most ideal but due to stringent ethical standards, patient availability, and limited funding, testing drug efficacy is mostly conducted on animal models. Therefore, it is considered critical to minimize the difference between human and animal disease models to accurately verify the effectiveness of the drug being tested.


Recently, a POSTECH research team led by Professor Sanguk Kim and Ph.D. candidate Doyeon Ha (Department of Life Sciences) has developed a technology to select genes from animal models to accurately mimic human diseases. Recently published in Nucleic Acids Research, an authoritative journal in the field of functional genomics, these findings are anticipated to help develop new drugs and effective therapeutics by engineering more precise animal models.

 

The research team analyzed the aggregate disease symptoms observed in human and mouse models using big data. Unlike conventional research that were conducted based on genomic sequence of orthologous genes across species, this study focused on the tissue-specific gene expression patterns and the gene regulatory networks they form.

 

Experimental analysis confirms that when the gene regulatory network of two species differ between human and mouse models, the mutation model of the target gene is not suitable for studying the human disease. Furthermore, analyzing the rewiring of the regulatory networks in human and mouse models help select an animal model that mimics the human disease with higher accuracy.

 

“Using this technology, we can predict the success or failure of animal disease models before making them and help develop more effective new drugs by better understanding disease mechanisms,” remarked Professor Sanguk Kim on the significance of the study.

 

This study was conducted with the support from the Medical Device Innovation Center and the Graduate School of Artificial Intelligence at POTSECH and from the Mid-career Researcher Program of the National Research Foundation of Korea.


Reference: Ha D, Kim D, Kim I, et al. Evolutionary rewiring of regulatory networks contributes to phenotypic differences between human and mouse orthologous genes. Nucleic Acids Research. 2022;50(4):1849-1863. doi: 10.1093/nar/gkac050


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement